These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33155841)

  • 21. Batatasin III Inhibits Migration of Human Lung Cancer Cells by Suppressing Epithelial to Mesenchymal Transition and FAK-AKT Signals.
    Pinkhien T; Petpiroon N; Sritularak B; Chanvorachote P
    Anticancer Res; 2017 Nov; 37(11):6281-6289. PubMed ID: 29061811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ponicidin inhibits pro-inflammatory cytokine TNF-α-induced epithelial-mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3β/Snail pathway.
    Zhang Z; Xu J; Liu B; Chen F; Li J; Liu Y; Zhu J; Shen C
    Inflammopharmacology; 2019 Jun; 27(3):627-638. PubMed ID: 30244296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
    Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C
    Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.
    Jin D; Cao M; Mu X; Yang G; Xue W; Huang Y; Chen H
    Cell Biochem Biophys; 2015 Apr; 71(3):1349-56. PubMed ID: 25388838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Momordica charantia MAP30 and its antitumor effect on bladder cancer cells.
    Hlin H; Zhi-Guo Z; Cong-Hui H; Yan Z; Qing L; Bo J; Hou-Guang H; Jun-Jie Z; Pei-Ying Z
    Minerva Urol Nefrol; 2016 Jun; 68(3):275-81. PubMed ID: 25517785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isorhapontigenin (ISO) inhibits EMT through FOXO3A/METTL14/VIMENTIN pathway in bladder cancer cells.
    Zhang N; Hua X; Tu H; Li J; Zhang Z; Max C
    Cancer Lett; 2021 Nov; 520():400-408. PubMed ID: 34332039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
    Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
    Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
    Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibitory effect of 2'-hydroxyflavanone on proliferation, invasion and migration of bladder cancer cells in vitro via blocking AKT/STAT3 signaling pathway].
    Zhu J; Wu K; Chen Y; Ning Z; Zhang K; DU Y; Ding C; Wang X; Fan J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Mar; 30(3):237-40. PubMed ID: 24606737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irisin suppresses the migration, proliferation, and invasion of lung cancer cells via inhibition of epithelial-to-mesenchymal transition.
    Shao L; Li H; Chen J; Song H; Zhang Y; Wu F; Wang W; Zhang W; Wang F; Li H; Tang D
    Biochem Biophys Res Commun; 2017 Apr; 485(3):598-605. PubMed ID: 27986567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ribosome-inactivating Protein MAP30 Isolated from
    Zhou Y; Yang D; Qiang Z; Meng Y; Li R; Fan X; Zhao W; Meng Y
    Recent Pat Anticancer Drug Discov; 2024; 19(2):223-232. PubMed ID: 36330636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
    Zhang L; Wang CZ; Ma M; Shao GF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8813-8822. PubMed ID: 31696468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
    Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
    IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway.
    Wang G; Cao R; Wang Y; Qian G; Dan HC; Jiang W; Ju L; Wu M; Xiao Y; Wang X
    Sci Rep; 2016 Oct; 6():35783. PubMed ID: 27779188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
    Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
    Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of multi and selective targeted tyrosine kinase inhibitors on function and signaling of different bladder cancer cells.
    Hänze J; Kessel F; Di Fazio P; Hofmann R; Hegele A
    Biomed Pharmacother; 2018 Oct; 106():316-325. PubMed ID: 29966976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isoflurane promotes epithelial-to-mesenchymal transition and metastasis of bladder cancer cells through HIF-1α-β-catenin/Notch1 pathways.
    Lu N; Piao MH; Feng CS; Yuan Y
    Life Sci; 2020 Oct; 258():118154. PubMed ID: 32735882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.